BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 23, 2006
View Archived Issues
De Novo enters drug discovery collaboration with Genzyme
Read More
Potent and selective AEA reuptake inhibitors as antispastics in MS
Read More
A.P. Pharma sells royalty rights to Retin-A Micro and Carac
Read More
New investment supports GammaCan's phase II study of GCAN-101
Read More
BioVeris signs option agreement with TheraCarb for C. albicans vaccine candidate
Read More
Merck Frosst presents a new potent, selective orally active cathepsin K inhibitor
Read More
Phase I study completed for KB-2115
Read More
Department of Defense grant for preclinical study of Tarvacin for prostate cancer
Read More
Positive phase III results for SPP-100 in hypertension
Read More
Shareholders vote in favor of Crucell's offer for Berna
Read More
NanoCarrier to conduct phase I study of Nanoplatin in U.K.
Read More
Tolamba shows clinical benefit in reducing symptoms of ragweed allergy
Read More
GdSSR: A novel putative approach for glioblastoma multiforme treatment
Read More
NovImmune files IND for antibody for autoimmune disease
Read More
EDP-420 begins North American phase II trial for CAP
Read More
Enrollment nearing completion in phase IIIb mesothelioma study of Onconase
Read More
Phase III development of Acapodene recommended to continue
Read More
Panzem studied in phase II for recurring GBM
Read More
Arteriocyte studies adult derived hemangioblasts to treat chronic ischemia
Read More
Procyon Biopharma and Cellpep to merge to form Ambrilia Biopharma
Read More
HPV-specific inhibitors from Boehringer Ingelheim as a gateway for future drug design
Read More
Novel agents imparted for inflammatory disorders
Read More
Taisho patent describes compounds with potential for the treatment for renal disorders, etc.
Read More
Recent patents cover novel treatments for psychological disorders
Read More
Neuroprotective effects of targeting IKK for stroke
Read More
New therapeutics for cancer covered in recent patent literature
Read More
SuperGen withdraws Orathecin MAA
Read More